相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
B. Flourie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
Jean Lachaine et al.
BMC GASTROENTEROLOGY (2013)
Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence
D. M. Evon et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®)
Francisco J. Acosta et al.
SCHIZOPHRENIA RESEARCH (2013)
One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis
A. Barney Hawthorne et al.
INFLAMMATORY BOWEL DISEASES (2012)
White Coat Adherence over the First Year of Therapy in Pediatric Epilepsy
Avani C. Modi et al.
JOURNAL OF PEDIATRICS (2012)
Guidelines for the management of inflammatory bowel disease in adults
Craig Mowat et al.
GUT (2011)
Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis
S. V. Kane et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Risk factors for non-adherence to medication in inflammatory bowel disease patients
R. D'Inca et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Adherence to topical therapy increases around the time of office visits
Steven R. Feldman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers
Peggy Gandia et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Systematic review: adherence issues in the treatment of ulcerative colitis
SV Kane
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
A new oral delivery system for 5-ASA: Preliminary clinical findings for MMx
C Prantera et al.
INFLAMMATORY BOWEL DISEASES (2005)
Modeling and simulation of adherence: Approaches and applications in therapeutics
LA Kenna et al.
AAPS JOURNAL (2005)
Enhancing adherence to long-term medical therapy: A new approach to assessing and treating patients
SL Aliotta et al.
ADVANCES IN THERAPY (2004)
Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease
MJ Shale et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Medication Nonadherence and the outcomes of patients with quiescent ulcerative colitis
S Kane et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Hospital admissions resulting from preventable adverse drug reactions
PJ McDonnell et al.
ANNALS OF PHARMACOTHERAPY (2002)
Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up
G Bresci et al.
DIGESTIVE AND LIVER DISEASE (2002)
Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication
R Horne et al.
PSYCHOLOGY & HEALTH (2002)
Patient adherence to treatment: three decades of research. A comprehensive review
E Vermeire et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2001)
Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis
PG Farup et al.
INFLAMMATORY BOWEL DISEASES (2001)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
DR Bangsberg et al.
AIDS (2001)
Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters
FN Hussain et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
分享论文
